Boardroom Alpha Digest: Thurs, Jan 19

by | Jan 19, 2023

Executive News

  • Longtime CEO (and Founder) Reed Hastings is stepping down as Co-CEO, but will remain as Executive Chairman for streaming giant Netflix Inc. (NFLX). COO Greg Peters has been promoted to Co-CEO alongside Ted Sarandos.
  • Kinder Morgan (KMI) CEO Steve Kean will step down in August and President Kim Dang will take over
  • John W. Gibson, Jr. has “transitioned” out of the roles of CEO and Chairman of Flotek Industries (FTK). Board member Harsha V. Agadi will be interim CEO while the company searches for a permanent replacement, and David Nierenberg has been named chairman.

Activist Situations

  • Trian Fund Management and Walt Disney Co. (DIS) continue to battle, and Trian today filed a collection of media content that appears to be in favor of Trian and/or Disney accepting Nelson Peltz as an addition to its board.

IPOS

  • Cadrenal Therapeutics (CVKD) is expected to price an IPO and trade tomorrow, January 20th, for an offering size of ~$7M

SPACs

  • Thrive Acquisition Corp. (THAC) announced that it will liquidate on 1/25 @ $10.36 per share
  • Broad Capital Acquisition Corp. (BRAC) announced a definitive agreement with Australian based Openmarkets Group for a $90M enterprise valuation.
  • Adara Acquisition Corp. (ADRA) shareholders approved its merger with Alliance Entertainment though, as mentioned earlier in the week, closing is subject to meeting or waiving of certain conditions including min cash and being listed on a major exchange. Both are in risk due to the high level of redemptions

SPAC Calendar

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.